Captopril prevents nephropathy in HIV-transgenic mice

Journal of the American Society of Nephrology

Volumn 9, Issue 8, 1998, Pages 1441-1447

  Bird, J Eileen ^a   Durham, Stephen K ^a   Giancarli, Mary R ^a   Gitlitz, Pete H ^a   Pandya, Darshana G ^a   Dambach, Donna M ^a   Mozes, Miklos M ^b   Kopp, Jeffrey B ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLOMERULOPATHY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; UREA NITROGEN BLOOD LEVEL;

EID: 0031928699     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bourgoignie JJ, Pardo V: The nephropathology in human immunodeficiency virus (HIV-1) infection. Kidney Int Suppl 35: S19-S35, 1991
2. Winston JA, Klotman PE: Are we missing an epidemic of HIV-associated nephropathy? J Am Soc Nephrol 7: 1-7, 1996
3. Rao TKS, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669-673, 1984
4. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 89: 1577-1581, 1992
5. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
7. Kimmel PL, Mishkin G, Umana W: Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 28: 202-208, 1996
8. Burns GC, Paul SK, Toth IR, Sivak SL: Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 8: 1140-1146, 1997
9. Wolf G, Ziyadeh FN, Zahner G, Stahl RAK: Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: Attenuation after stable transfection with c-mas oncogene. Kidney Int 48: 1818-1827, 1995
10. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992
11. Shehata M, Cope GH, Johnson TS, Raftery AT, Nahas AME: Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells of the rat kidney. Kidney Int 48: 1487-1496, 1995
12. Kopp JB, McCune BK, Notkins AL, Sporn MB, Klotman PE: Increased expression of transforming growth factor beta (TGF) in HIV-transgenic mouse kidney [Abstract]. J Am Soc Nephrol 3: 600, 1992
13. Bodi I, Kimmel PL, Abraham AA, Svetkey LP, Klotman PE, Kopp JB: Renal TGF-β in HIV-associated kidney diseases. Kidney Int 51: 1568-1577, 1997
14. El Nahas AM, Bassett AH, Cope GH, Le Carpentier JE: Role of growth hormone in the development of experimental renal scarring. Kidney Int 40: 29-34, 1991
15. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 29: 153-163, 1997
16. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke H, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
17. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541-549, 1990
18. Hahn AWA, Resnick TJ, Bernhardt J, Ferracin F, Buhler FR: Stimulation of autocrine platelet derived growth factor AA-homodimer and transforming growth factor β in vascular smooth muscle cells. Biochem Biophys Res Commun 178: 1451-1458, 1991
19. Stouffer GA, Owens GK: Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ Res 70: 820-828, 1992
20. Lee LK, Meyer TW, Pollock AS, Lovett DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 96: 953-964, 1995
21. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992